U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07116356) titled 'Molecular Characterization of Carbapenemase-Producing Enterobacterales' on Aug. 04.
Brief Summary: Bacterial infections with carbapenem resistant pathogens are one of the major threats in immunocompromised patients, especially among cancer patients .Furthermore, Gram negative pathogens are becoming increasingly prevalent and have become an ongoing global health concern .Emergence of Gram-negative pathogens, especially Enterobacterales that avert many of the human defense mechanisms are alarmingly increasing and most of these pathogens are resistant to many of the in-use antibiotics including carbapenems .
Study Start Date: Sept. 10...